Stockscreener 앱 받기
4.85
19.75%
0.80
시간 외 거래:
4.58
-0.27
-5.57%
전일 마감가:
$4.05
열려 있는:
$4.3
하루 거래량:
35,310
Relative Volume:
0.33
시가총액:
$13.17M
수익:
-
순이익/손실:
$-8.09M
주가수익비율:
-29.98
EPS:
-0.1618
순현금흐름:
$-8.31M
1주 성능:
+17.43%
1개월 성능:
-16.52%
6개월 성능:
-14.01%
1년 성능:
-89.00%
1일 변동 폭
$4.26
$4.85
1주일 범위
$3.96
$4.85
52주 변동 폭
$3.78
$47.10
Abpro Holdings Inc Stock (ABP) Company Profile
명칭
Abpro Holdings Inc
전화
248-890-7200
주소
6 ST JOHNS LANE, FLOOR 5, NEW YORK
ABP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABP
Abpro Holdings Inc
|
4.85 | 11.00M | 0 | -8.09M | -8.31M | -0.1618 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Abpro Holdings Inc 주식(ABP)의 최신 뉴스
Abpro stock rises after FDA clearance for solid tumor program By Investing.com - Investing.com South Africa
FDA clears Abpro and Celltrion’s solid tumor therapy for clinical trial - Investing.com Australia
FDA Clears Abpro’s Lead HER2 Cancer Drug for Phase 1 - TipRanks
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance for Lead Multispecific Antibody Cancer Candidate ABP-102 / CT-P72 - The Manila Times
Abpro and Celltrion, Inc. Announce U.S. FDA IND Clearance - GlobeNewswire
Abpro stock rises after FDA clearance for solid tumor program - Investing.com
Published on: 2025-12-30 01:00:17 - moha.gov.vn
Aug Levels: Why Abpro Holdings Inc stock could rally in 2025July 2025 Price Swings & AI Forecasted Entry/Exit Points - moha.gov.vn
Abpro Holdings Inc. (NASDAQ:ABP) Short Interest Update - Defense World
Aug Selloffs: How Abpro Holdings Inc. Equity Warrant stock reacts to job market dataTrade Volume Report & Fast Gain Stock Tips - Улправда
How Abpro Holdings Inc. Equity Warrant stock valuations compare to rivalsQuarterly Profit Report & Expert Curated Trade Ideas - Улправда
Why Abpro Holdings Inc. stock is a value investor pickCPI Data & Technical Pattern Recognition Alerts - Улправда
Is Abpro Holdings Inc. Equity Warrant stock a smart buy before Fed meetingTrade Risk Assessment & Weekly Momentum Picks - Улправда
How Abpro Holdings Inc. stock compares to industry benchmarksJuly 2025 Selloffs & Weekly Chart Analysis and Guides - Улправда
How Abpro Holdings Inc. Equity Warrant stock benefits from tech adoptionQuarterly Trade Report & Free Weekly Watchlist of Top Performers - Улправда
Net current asset value per share of Abpro Holdings, Inc. Warrant 2024-12.11.29 on Abpro Hldgs – NASDAQ:ABPWW - TradingView — Track All Markets
How Abpro Holdings Inc. Equity Warrant stock reacts to job market dataJuly 2025 Trade Ideas & AI Driven Price Predictions - Улправда
Can Abpro Holdings Inc. Equity Warrant stock rebound after recent weaknessQuarterly Trade Summary & Free Growth Oriented Trading Recommendations - Улправда
What Wall Street predicts for Abpro Holdings Inc. stock priceTrade Performance Summary & Daily Growth Stock Investment Tips - DonanımHaber
Why Abpro Holdings Inc. Equity Warrant stock remains undervalued - Улправда
How interest rate cuts could boost Abpro Holdings Inc. stockWeekly Profit Report & Safe Capital Growth Plans - DonanımHaber
Abpro (NASDAQ:ABP) Stock Price Up 0.2% – Still a Buy? - Defense World
Chipmakers Recap: How Abpro Holdings Inc. stock compares to industry benchmarks2025 Volatility Report & Target Return Focused Stock Picks - Улправда
Abpro Hldgs (ABP) Stock Analysis Report | Financials & Insights - Benzinga
Aug Patterns: How Abpro Holdings Inc. Equity Warrant stock valuations compare to rivals2025 Market Sentiment & AI Forecasted Stock Moves - ulpravda.ru
Abpro and Celltrion announce IND filing for T-cell engager - BioWorld MedTech
Abpro Holdings submits IND application for Phase 1 trial of ABP102/CT-P72 - TipRanks
Abpro Holdings Submits IND Application for Cancer Drug - TipRanks
Abpro Holdings, Inc. Submits IND for Phase 1 Trial of ABP-102/CT-P72 - TradingView — Track All Markets
Abpro Holdings (NASDAQ: ABP) discloses IND filing for HER2 therapy - Stock Titan
Abpro Holdings announces submission of an IND application to initiate a Phase 1 clinical trial of T cell engager ABP-102/CT-P72 for HER2-positive cancers - marketscreener.com
Abpro Holdings Announces Submission of an IND Application to Initiate a Phase 1 Clinical Trial of T cell engager ABP-102/CT-P72 for HER2-positive Cancers - TradingView — Track All Markets
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Abpro Holdings Announces Submission of an IND Application - GlobeNewswire
Abpro secures NASDAQ extension to regain compliance with listing rules - MSN
Abpro Holdings Granted Nasdaq Compliance Extension - TipRanks
Abpro Holdings granted Nasdaq compliance extension - MSN
Abpro Holdings, Inc. Granted Nasdaq Listing Extension - TradingView — Track All Markets
Abpro Granted Nasdaq Listing Extension to Pursue Compliance and Strategic Objectives - marketscreener.com
Fed Watch: Will Abpro Holdings Inc stock reach all time highs in 2025Trade Entry Report & Fast Momentum Stock Entry Tips - moha.gov.vn
What catalysts could drive Abpro Holdings Inc. stock higherFed Meeting & High Return Stock Watch Alerts - Newser
How Abpro Holdings Inc. stock performs in rate cut cyclesJuly 2025 Pullbacks & Reliable Breakout Forecasts - Newser
How Abpro Holdings Inc. stock performs in weak economyJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Can Abpro Holdings Inc. stock outperform in 2025 bull marketForecast Cut & High Win Rate Trade Alerts - Newser
Will Abpro Holdings Inc. stock reach all time highs in 2025Quarterly Risk Review & Real-Time Volume Trigger Notifications - Newser
Can Abpro Holdings Inc. Equity Warrant stock maintain operating marginsJuly 2025 Summary & Expert-Curated Trade Recommendations - moha.gov.vn
Wall Street Recap: How Abpro Holdings Inc. stock compares to industry benchmarksAnalyst Downgrade & Real-Time Sentiment Analysis - BỘ NỘI VỤ
Abpro (ABP) versus Its Competitors Head to Head Review - Defense World
Abpro Holdings, Celltrion to present preclinical data for CT-P72/ABP-102 - MSN
Can Abpro Holdings Inc. rally from current levelsAnalyst Downgrade & Safe Capital Preservation Plans - newser.com
Is Abpro Holdings Inc. stock resilient to inflation2025 Valuation Update & Real-Time Stock Movement Alerts - newser.com
Abpro Holdings Inc (ABP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.52%
0.07%
자본화:
|
볼륨(24시간):